OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!

They Said “2–3 Months to Live” — 10 Years Later, He's Thriving | Dr. Dino Prato

This episode explores challenging medical prognoses, from inoperable tumors to dire timelines, highlighting the critical need for advanced patient care. Dr. Prato discusses how precise oncology approaches can offer hope, even when traditional healthcare options seem limited. By focusing on personalized cancer treatment, we aim to redefine what's possible for every cancer patient. 🎯 What You’ll Learn in This Episode: • What “2–3 months to live” typically means clinically • Why cancer varies between patients • The role of deeper biological testing • What multi-omics analysis includes • Why monitoring between scans matters • The concept of immune-focused treatment strategies • 5 key questions to ask your doctor • How treatment planning may evolve over time 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com [https://www.envita.com/?utm_source=DrDinoPodcast] 📞 Speak with a care coordinator: 866-830-4576 “When cancer is complex, decisions should be guided by deeper data — not just timelines.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493 [https://www.scirp.org/journal/paperinformation?paperid=132493]

Root Canals & Cancer — What Patients Need to Know | Dr. Dino Prato

When a 52-year-old woman experienced breast cancer recurrence after initial radiation therapy, her oncologist considered a stronger chemotherapy regimen. However, her compromised immune system and high inflammation in the body indicated a need for a different approach. In this episode, Dr. Prato focuses on performing a root cause analysis to address these deeper issues, moving beyond just cancer treatment. 🎯 What You’ll Learn in This Episode: • Do root canals cause cancer? • How oral infections may impact immune function • What microleakage means in dentistry • Why some infections go unnoticed • The connection between inflammation and cancer • Signs of possible oral health issues • Why proper dental evaluation matters • How oral health fits into a broader care strategy 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com [https://www.envita.com/?utm_source=DrDinoPodcast] 📞 Speak with a care coordinator: 866-830-4576 “The mouth is not separate from the body — it’s part of the immune system.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493 [https://www.scirp.org/journal/paperinformation?paperid=132493]

7 Foods That Support Mitochondria & Energy in Cancer Patients | Dr. Dino Prato

Ever wonder why you feel tired even after a full night's sleep? This episode explores the vital connection between what we eat and our energy levels, especially for those undergoing cancer treatment. Dr. Prato highlights how proper nutrition and healthy food choices act as "food as medicine" to support mitochondrial health, the true "powerhouse of the cell," ultimately helping to boost energy and promote a more vibrant, healthy lifestyle. 🎯 What You’ll Learn in This Episode: • Why mitochondria are important in cancer care • How energy production affects recovery and resilience • The role of diet in supporting cellular function • 7 foods that may support mitochondrial health • Why gut health and immunity are connected • The impact of inflammation on energy levels • Why consistency matters more than perfection • How nutrition fits into a broader treatment strategy 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com [https://www.envita.com/?utm_source=DrDinoPodcast] 📞 Speak with a care coordinator: 866-830-4576 “Energy at the cellular level supports resilience at the whole-body level.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493 [https://www.scirp.org/journal/paperinformation?paperid=132493]

Cancer Is Chess, Not Checkers — Why Strategy Matters in Treatment | Dr. Dino Prato

This episode critically examines the conventional approach to cancer treatment, suggesting that current health care strategies often resemble playing 'checkers' against a 'chess' opponent. Dr. Dino Prato points out the significant mistake in applying a 'one-size-fits-all' medicine for advanced oncology cases, where standard regimens are tried sequentially. The discussion emphasizes how this approach can lead to patient weakening before clinical trials or personalized solutions are considered, highlighting the need for a more strategic perspective in medical care. 🎯 What You’ll Learn in This Episode: • Why cancer is compared to chess, not checkers • How tumors evolve and adapt over time • Why standard treatment sequences may fall short in complex cases • What deeper biological testing can reveal • The role of tumor microenvironment and immune response • Why strategy matters in advanced cancer care • The importance of individualized treatment planning • Questions to ask your doctor about treatment strategy 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com [https://www.envita.com/?utm_source=DrDinoPodcast] 📞 Speak with a care coordinator: 866-830-4576 “Cancer adapts — so treatment must be strategic, not reactive.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493 [https://www.scirp.org/journal/paperinformation?paperid=132493]

Why Immunotherapy Fails Most Patients — The Truth About Keytruda Doctors Don’t Explain

Dr. Dino Prato discusses custom-building immunotherapy, highlighting its limitations and potential for patients with stage four melanoma. He explains that treatments like Keytruda only work long-term for a small percentage of patients and that many are not candidates due to "cold" tumors, an important aspect of modern oncology. Dr. Dino Prato explores how advancements in immunotherapy for cancer are shaping the future of cancer treatment, emphasizing the role of the immune system in fighting the disease. 🎯 What You’ll Learn in This Episode • Why immunotherapy doesn’t work for all patients • What checkpoint inhibitors actually do • The role of immune signaling in cancer response • Why tumor biology differs between patients • What “cold tumors” mean • How tumor microenvironment affects treatment • Why deeper testing is being explored • How personalized approaches may guide care 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com [https://www.envita.com/?utm_source=DrDinoPodcast] 📞 Speak with a care coordinator: 866-830-4576 “Immunotherapy isn’t one-size-fits-all — it depends on how your immune system and tumor interact.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493 [https://www.scirp.org/journal/paperinformation?paperid=132493]